应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02252 微创机器人-B
国庆日翌日休市 09-29 16:08:22
18.100
+0.020
+0.11%
最高
18.280
最低
17.700
成交量
15.45万
今开
18.080
昨收
18.080
日振幅
3.21%
总市值
173.51亿
流通市值
172.31亿
总股本
9.59亿
成交额
278.56万
换手率
0.02%
流通股本
9.52亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股概念追踪 | 傅利叶GR-1开启预售 人形机器人商业化可期(附概念股)
智通财经网 · 09-28
港股概念追踪 | 傅利叶GR-1开启预售 人形机器人商业化可期(附概念股)
华为史上最燃发布会!麒麟鸿鹄自研芯片炸场,刘德华手持Mate 60“超大杯”现身
智东西 · 09-25
华为史上最燃发布会!麒麟鸿鹄自研芯片炸场,刘德华手持Mate 60“超大杯”现身
华为发布首款隔空触控电视 搭载鸿鹄900芯片
新浪科技 · 09-25
华为发布首款隔空触控电视 搭载鸿鹄900芯片
850万辆电动车,装不下新势力们的“鸿鹄志”
雪豹财经社 · 09-21
850万辆电动车,装不下新势力们的“鸿鹄志”
微创机器人-B09月19日主力资金流出226万元 连续3日减仓
自选股智能写手 · 09-19
微创机器人-B09月19日主力资金流出226万元 连续3日减仓
微创机器人-B现涨近7% 鸿鹄髋膝关节置换手术机器人获上市批准
新浪港股 · 09-19
微创机器人-B现涨近7% 鸿鹄髋膝关节置换手术机器人获上市批准
【港股通】微创机器人(02252)短线升逾9% 鸿鹄髋膝关节置换手术机器人获得国家药监局上市批准
凤凰网港股 · 09-19
【港股通】微创机器人(02252)短线升逾9% 鸿鹄髋膝关节置换手术机器人获得国家药监局上市批准
港股异动 | 微创机器人-B(02252)急涨超9% 鸿鹄髋膝关节置换手术机器人获国家药监局上市批准
智通财经 · 09-19
港股异动 | 微创机器人-B(02252)急涨超9% 鸿鹄髋膝关节置换手术机器人获国家药监局上市批准
微创机器人-B盘中异动 早盘股价大涨5.14%报18.400港元
自选股智能写手 · 09-19
微创机器人-B盘中异动 早盘股价大涨5.14%报18.400港元
微创机器人-B(02252.HK):鸿鹄髋膝关节置换手术机器人获得国家药品监督管理局上市批准
格隆汇资讯 · 09-18
微创机器人-B(02252.HK):鸿鹄髋膝关节置换手术机器人获得国家药品监督管理局上市批准
微创机器人-B(02252)自主研发的鸿鹄髋膝关节置换手术机器人获得NMPA上市批准
智通财经 · 09-18
微创机器人-B(02252)自主研发的鸿鹄髋膝关节置换手术机器人获得NMPA上市批准
微创机器人-B盘中异动 临近收盘快速拉升5.46%报17.780港元
自选股智能写手 · 09-15
微创机器人-B盘中异动 临近收盘快速拉升5.46%报17.780港元
花旗:维持微创机器人-B“买入/高风险”评级 目标价下调至45港元
新浪港股 · 09-14
花旗:维持微创机器人-B“买入/高风险”评级 目标价下调至45港元
花旗发布研究报告称,维持微创机器人-B(02252.HK)“买入/高风险”评级,并预计其会于2025年实现盈亏平衡
证券之星 · 09-14
花旗发布研究报告称,维持微创机器人-B(02252.HK)“买入/高风险”评级,并预计其会于2025年实现盈亏平衡
大行评级|花旗:下调微创机器人目标价至45港元 评级“买入”
格隆汇资讯 · 09-14
大行评级|花旗:下调微创机器人目标价至45港元 评级“买入”
【券商聚焦】广发证券维持微创机器人-B(02252)“买入”评级 多产品启动商业化
凤凰网港股 · 09-07
【券商聚焦】广发证券维持微创机器人-B(02252)“买入”评级 多产品启动商业化
微创机器人-B(02252.HK):9月5日南向资金增持7500股
证券之星 · 09-06
微创机器人-B(02252.HK):9月5日南向资金增持7500股
浦银国际:维持微创机器人-B(02252)“买入”评级 目标价下调至30港元
智通财经网 · 09-05
浦银国际:维持微创机器人-B(02252)“买入”评级 目标价下调至30港元
港股异动 | 微创机器人-B(02252)跌超7% 上半年亏损扩大至5.39亿 机构称商业化推广顺利
智通财经 · 09-05
港股异动 | 微创机器人-B(02252)跌超7% 上半年亏损扩大至5.39亿 机构称商业化推广顺利
加载更多
公司概况
公司名称:
微创机器人-B
所属市场:
SEHK
上市日期:
--
主营业务:
上海微创医疗机器人(集团)股份有限公司是一家从事手术器械开发的公司。 该公司的主营业务是创新手术机器人的设计、开发和商业化。该公司的产品包括图迈腔镜手术机器人、蜻蜓眼三维电子腹腔内窥镜和鸿鹄骨科手术机器人。该公司的手术机器人应用于多个微创手术领域,包括内窥镜手术、骨科手术、泛血管手术、自然腔手术和经皮穿刺手术。 该公司还提供手术机器人Medbot的教育培训服务。
发行价格:
--
{"stockData":{"symbol":"02252","market":"HK","secType":"STK","nameCN":"微创机器人-B","latestPrice":18.1,"timestamp":1695974902031,"preClose":18.08,"halted":0,"volume":154500,"delay":0,"floatShares":951994288,"shares":958593831,"eps":-1.2755144,"marketStatus":"国庆日翌日休市","marketStatusCode":7,"change":0.02,"latestTime":"09-29 16:08:22","open":18.08,"high":18.28,"low":17.7,"amount":2785578,"amplitude":0.03208,"askPrice":18.1,"askSize":2000,"bidPrice":18.02,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-1.3649948551488613,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1696296600000},"adr":0,"listingDate":1635782400000,"adjPreClose":18.08,"volumeRatio":0.38956127074288033,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02252","defaultTab":"news","newsList":[{"id":"2370711453","title":"港股概念追踪 | 傅利叶GR-1开启预售 人形机器人商业化可期(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2370711453","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2370711453?lang=zh_cn&edition=full","pubTime":"2023-09-28 07:37","pubTimestamp":1695857839,"startTime":"0","endTime":"0","summary":"9月26日,傅利叶智能宣布,通用人形机器人GR-1开启对外预售。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20230928/20230928073725_44534.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20230928/20230928073725_44534.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1000942.html","is_publish_highlight":false},{"id":"2370662265","title":"华为史上最燃发布会!麒麟鸿鹄自研芯片炸场,刘德华手持Mate 60“超大杯”现身","url":"https://stock-news.laohu8.com/highlight/detail?id=2370662265","media":"智东西","top":-1,"share":"https://www.laohu8.com/m/news/2370662265?lang=zh_cn&edition=full","pubTime":"2023-09-25 18:00","pubTimestamp":1695636000,"startTime":"0","endTime":"0","summary":"华为最近开售的几款Mate系列手机,可以说款款都是“电子茅台”。目前华为Mate 60全系均处于缺货状态,华为Mate X5典藏版的三方现货售价甚至达到了27699元,溢价超过万元。不过这次华为并没有在发布会上具体介绍华为Mate 60 RS非凡大师版,而是在发布会后直接放出了该产品的相关介绍。根据华为官方海报信息,华为Mate 60 RS非凡大师版的起售价格为11999元,最高存储16GB+1TB,售价12999元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"fenghuang_stock","url":"https://tech.ifeng.com/c/8TN8HmAGXfx","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8TN8HmAGXfx","is_publish_highlight":false},{"id":"2370040259","title":"华为发布首款隔空触控电视 搭载鸿鹄900芯片","url":"https://stock-news.laohu8.com/highlight/detail?id=2370040259","media":"新浪科技","top":-1,"share":"https://www.laohu8.com/m/news/2370040259?lang=zh_cn&edition=full","pubTime":"2023-09-25 15:39","pubTimestamp":1695627540,"startTime":"0","endTime":"0","summary":"新浪科技讯 9月25日下午消息,在今日的华为秋季全场景新品发布会上,华为终端BG首席运营官何刚发表演讲。\n 会上,华为智慧屏 V5 Pro发布,搭载全球首创灵犀指向交互,带来滑动、点按、拖拽等手机上才有的操控体验,让操控大屏像玩手机一样简单。得益于超小型天线,灵犀空间定位等自研技术,华为智慧屏 V5 Pro成为全球首款支持绝对指向交互的大屏。\n\n 另外,华为智慧屏V5 Pro搭载鸿鹄900芯片,何刚表示,该芯片在CPU、GPU、NPU多个方面实现性能提升。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:韦子蓉","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/tech/it/2023-09-25/doc-imznxecf2254384.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/it/2023-09-25/doc-imznxecf2254384.shtml","is_publish_highlight":false},{"id":"2369127295","title":"850万辆电动车,装不下新势力们的“鸿鹄志”","url":"https://stock-news.laohu8.com/highlight/detail?id=2369127295","media":"雪豹财经社","top":-1,"share":"https://www.laohu8.com/m/news/2369127295?lang=zh_cn&edition=full","pubTime":"2023-09-21 09:01","pubTimestamp":1695258086,"startTime":"0","endTime":"0","summary":"新势力们的成绩尤为惨淡。吉利旗下纯电品牌极氪,今年前8个月累计交付了6.7万辆汽车,尚未完成14万辆年交付目标的50%。乘联会预测,2023年国内新能源乘用车销量为850万辆,同比增长30%。行业快于预期的发展,给了新旧势力们制定乐观甚至激进目标的信心。2022年全年,造车新势力第一梯队的“蔚小理哪零”中,只有哪咤完成了年度KPI。2021年5月,长城汽车发布公告,拟授予激励对象股票期权39710.1万份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"fenghuang_stock","url":"https://tech.ifeng.com/c/8TFubOFXP2L","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8TFubOFXP2L","is_publish_highlight":false},{"id":"2368309971","title":"微创机器人-B09月19日主力资金流出226万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2368309971","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2368309971?lang=zh_cn&edition=full","pubTime":"2023-09-19 16:16","pubTimestamp":1695111392,"startTime":"0","endTime":"0","summary":"09月19日, 微创机器人-B股价涨5.49%,报收18.46元,成交金额4980万元,换手率0.28%,振幅12.23%,量比4.38。微创机器人-B今日主力资金净流出226万元,连续3日净流出,上一交易日主力净流出0万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为36.36%,平均跌幅为1.86%。该股近5个交易日上涨10.00%,主力资金累计净流出102万元;近20日主力资金累计净流出145万元,其中净流出天数为6日。该股主力净额占比0.01%,港股市场排名2470/2614。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023091916170482579b77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023091916170482579b77&s=b","is_publish_highlight":false},{"id":"2368992131","title":"微创机器人-B现涨近7% 鸿鹄髋膝关节置换手术机器人获上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2368992131","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2368992131?lang=zh_cn&edition=full","pubTime":"2023-09-19 11:35","pubTimestamp":1695094553,"startTime":"0","endTime":"0","summary":"微创机器人-B(02252)早盘急涨6.63%,现报18.66港元,成交额3610.098万港元。\n 微创机器人公布,自主研发的鸿鹄骨科关节置换手术导航定位系统(鸿鹄髋膝关节置换手术机器人)正式通过国家药品监督管理局(NMPA)上市批准,成为获批的首个搭载自研机械臂的国产髋膝一体骨科手术机器人。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2023-09-19/doc-imznfexn8393946.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2023-09-19/doc-imznfexn8393946.shtml","is_publish_highlight":false},{"id":"2368927492","title":"【港股通】微创机器人(02252)短线升逾9% 鸿鹄髋膝关节置换手术机器人获得国家药监局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2368927492","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2368927492?lang=zh_cn&edition=full","pubTime":"2023-09-19 11:07","pubTimestamp":1695092837,"startTime":"0","endTime":"0","summary":"微创机器人(02252)临近午盘短线拉升,截至发稿,涨9.6%,报19.18港元,成交额2624.06万港元。消息面上,公司公布,集团自主研发的鸿鹄骨科关节置换手术导航定位系统(鸿鹄髋膝关节置换手术机器人)正式通过国家药品监督管理局(NMPA)上市批准,成为获批的首个搭载自研机械臂的国产髋膝一体骨科手术机器人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=99efa5f88ec33299c2602c4fe74e767e","is_publish_highlight":false},{"id":"2368926430","title":"港股异动 | 微创机器人-B(02252)急涨超9% 鸿鹄髋膝关节置换手术机器人获国家药监局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2368926430","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2368926430?lang=zh_cn&edition=full","pubTime":"2023-09-19 10:51","pubTimestamp":1695091902,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,微创机器人-B(02252)急涨超9%,截至发稿,涨9.14%,报19.1港元,成交额1431.5万港元。消息面上,微创机器人公告,集团自主研发的鸿鹄骨科关节置换手术导航定位系统(鸿鹄髋膝关节置换手术机器人)正式通过国家药品监督管理局(NMPA)上市批准,成为获批的首个搭载自研机械臂的国产髋膝一体骨科手术机器人。据悉,微创机器人是目前全球唯一一家业务覆盖腔镜、骨科、泛血管、经自然腔道和经皮穿刺五大赛道的手术机器人公司,已有 10 余款产品处于产业化项目快速推进阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/996486.html","is_publish_highlight":false},{"id":"2368926618","title":"微创机器人-B盘中异动 早盘股价大涨5.14%报18.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2368926618","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2368926618?lang=zh_cn&edition=full","pubTime":"2023-09-19 10:47","pubTimestamp":1695091670,"startTime":"0","endTime":"0","summary":"2023年09月19日早盘10时47分,微创机器人-B股票出现波动,股价大幅拉升5.14%。截至发稿,该股报18.400港元/股,成交量50.3万股,换手率0.05%,振幅5.94%。资金方面,该股资金流入390.555万港元,流出383.436万港元。其相关个股中,永胜医疗、微创机器人-B、爱康医疗涨幅较大,振幅较大的相关个股有永胜医疗、中国卫生集团、爱康医疗,振幅分别为9.59%、8.47%、7.18%。消息层面,截至10时47分,微创机器人-B股票正面舆情新闻比例66.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023091910475082f4ce13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023091910475082f4ce13&s=b","is_publish_highlight":false},{"id":"2368745992","title":"微创机器人-B(02252.HK):鸿鹄髋膝关节置换手术机器人获得国家药品监督管理局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2368745992","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2368745992?lang=zh_cn&edition=full","pubTime":"2023-09-18 20:54","pubTimestamp":1695041686,"startTime":"0","endTime":"0","summary":"格隆汇9月18日丨微创机器人-B公告,集团自主研发的鸿鹄骨科关节置换手术导航定位系统正式通过国家药品监督管理局上市批准,成为获批的首个搭载自研机械臂的国产髋膝一体骨科手术机器人。作为目前唯一自研机械臂的髋膝兼容国产骨科手术机器人,鸿鹄髋膝关节置换手术机器人能够在术中精准定位,精准进行膝关节截骨和髋臼磨削,精准恢复患者下肢力线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202309182056028255067d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202309182056028255067d&s=b","is_publish_highlight":false},{"id":"2368399275","title":"微创机器人-B(02252)自主研发的鸿鹄髋膝关节置换手术机器人获得NMPA上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2368399275","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2368399275?lang=zh_cn&edition=full","pubTime":"2023-09-18 20:52","pubTimestamp":1695041564,"startTime":"0","endTime":"0","summary":"智通财经APP讯,微创机器人-B 公布,该集团自主研发的鸿鹄骨科关节置换手术导航定位系统正式通过国家药品监督管理局上市批准,成为获批的首个搭载自研机械臂的国产髋膝一体骨科手术机器人。公告称,鸿鹄髋膝关节置换手术机器人获得NMPA批准,是该集团在关节外科治疗领域实现的又一重要里程碑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/996322.html","is_publish_highlight":false},{"id":"2367696039","title":"微创机器人-B盘中异动 临近收盘快速拉升5.46%报17.780港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2367696039","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2367696039?lang=zh_cn&edition=full","pubTime":"2023-09-15 16:03","pubTimestamp":1694765039,"startTime":"0","endTime":"0","summary":"2023年09月15日临近收盘16时03分,微创机器人-B股票出现异动,股价快速拉升5.46%。截至发稿,该股报17.780港元/股,成交量71.6218万股,换手率0.08%,振幅2.97%。微创机器人-B股票所在的医疗设备及用品行业中,整体跌幅为0.40%。其相关个股中,隽泰控股、云能国际、诺辉健康涨幅较大,振幅较大的相关个股有健世科技-B、紫元元、春立医疗,振幅分别为17.78%、10.63%、9.63%。消息层面,截至16时03分,微创机器人-B股票正面舆情新闻比例80%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230915160400838c06f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230915160400838c06f7&s=b","is_publish_highlight":false},{"id":"2367501001","title":"花旗:维持微创机器人-B“买入/高风险”评级 目标价下调至45港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2367501001","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2367501001?lang=zh_cn&edition=full","pubTime":"2023-09-14 16:37","pubTimestamp":1694680620,"startTime":"0","endTime":"0","summary":" 花旗发布研究报告称,维持微创机器人-B“买入/高风险”评级,并预计其会于2025年实现盈亏平衡。另称反贪腐运动预将进一步影响第三季经营,预计销售增长将推迟至第四季至明年首季,相应将2023至25年收入预测下调47%/13%/17%,目标价由50港元下调至45港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/tob/2023-09-14/doc-imzmsnee6382006.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2023-09-14/doc-imzmsnee6382006.shtml","is_publish_highlight":false},{"id":"2367596501","title":"花旗发布研究报告称,维持微创机器人-B(02252.HK)“买入/高风险”评级,并预计其会于2025年实现盈亏平衡","url":"https://stock-news.laohu8.com/highlight/detail?id=2367596501","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2367596501?lang=zh_cn&edition=full","pubTime":"2023-09-14 16:31","pubTimestamp":1694680297,"startTime":"0","endTime":"0","summary":"另称反贪腐运动预将进一步影响第三季经营,预计销售增长将推迟至第四季至明年首季,相应将2023至25年收入预测下调47%/13%/17%,目标价由50港元下调至45港元。截至2023年9月14日收盘,微创机器人-B报收于16.86港元,上涨0.84%,换手率0.08%,成交量78.5万股,成交额1316.62万港元。投行对该股的评级以买入为主,近90天内共有2家投行给出买入评级,近90天的目标均价为28.34港元。广发证券最新一份研报给予微创机器人-B买入评级,目标价26.69港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202309141631468249809d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202309141631468249809d&s=b","is_publish_highlight":false},{"id":"2367577933","title":"大行评级|花旗:下调微创机器人目标价至45港元 评级“买入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2367577933","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2367577933?lang=zh_cn&edition=full","pubTime":"2023-09-14 13:41","pubTimestamp":1694670106,"startTime":"0","endTime":"0","summary":"花旗发表研究报告指,微创机器人中期收入按年增长44%至4,800万元,较该行预测低约13%,期内录净亏损约5.39亿元,毛利率从2022年上半年的65.9%下降至46.4%,研发费用亦下降约7%,销售费用则增长近一倍至1.27亿元。报告指出,由于大型设备配置许可配额发放得较晚,导致公司的旗舰产品图迈图迈手术机器人商业化进展亦较预期慢,今年上半年共中标三份合约。花旗将微创机器人目标价从50港元下调至45港元,维持“买入”评级,并预期公司会于2025年实现盈亏平衡。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202309141343058248fbb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202309141343058248fbb3&s=b","is_publish_highlight":false},{"id":"2365884600","title":"【券商聚焦】广发证券维持微创机器人-B(02252)“买入”评级 多产品启动商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2365884600","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2365884600?lang=zh_cn&edition=full","pubTime":"2023-09-07 14:06","pubTimestamp":1694066774,"startTime":"0","endTime":"0","summary":"广发证券研报指,微创机器人-B发布2023年中报业绩,公司实现营业收入4760万元,较上年同期收入人民币100万元实现大幅增长。核心产品图迈发挥其于国产手术机器人行列的领先优势,保持良好的商业化势头。该行指,MonaLisa已递交NMPA注册申请,预计23年内获得批准,且Mona Lisa已成功开拓中国台湾市场,完成首台设备销售。据DCF估值,对应合理价值为26.69港元/股,维持“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=f290eb8b2a47e638a0128e7a8d32e3ba","is_publish_highlight":false},{"id":"2365062254","title":"微创机器人-B(02252.HK):9月5日南向资金增持7500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2365062254","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2365062254?lang=zh_cn&edition=full","pubTime":"2023-09-06 03:41","pubTimestamp":1693942901,"startTime":"0","endTime":"0","summary":"近5个交易日中,获南向资金减持的有4天,累计净减持66.35万股。截至目前,南向资金持有微创机器人-B2801.38万股,占公司已发行普通股的2.93%。上海微创医疗机器人(集团)股份有限公司是一家从事手术器械开发的公司。该公司的主营业务是创新手术机器人的设计、开发和商业化。该公司的产品包括图迈腔镜手术机器人、蜻蜓眼三维电子腹腔内窥镜和鸿鹄骨科手术机器人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230906034221822e4a2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230906034221822e4a2a&s=b","is_publish_highlight":false},{"id":"2365419034","title":"浦银国际:维持微创机器人-B(02252)“买入”评级 目标价下调至30港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2365419034","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2365419034?lang=zh_cn&edition=full","pubTime":"2023-09-05 16:49","pubTimestamp":1693903762,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,浦银国际发布研究报告称,维持微创机器人-B“买入”评级,短期受医疗反腐、现金储备压力影响,下调目标价至30港元。公司1H23图迈新增装机不及预期,部分受二代产品获批延后及“十四五”配置证规划数于6月才公布影响。8月初以来医疗反腐对大型设备招投标产生影响,手术机器人作为高值设备,入院节奏或将放缓。该行看好手术机器人“渗透率提升+国产替代”长期逻辑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/991043.html","is_publish_highlight":false},{"id":"2365588085","title":"港股异动 | 微创机器人-B(02252)跌超7% 上半年亏损扩大至5.39亿 机构称商业化推广顺利","url":"https://stock-news.laohu8.com/highlight/detail?id=2365588085","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2365588085?lang=zh_cn&edition=full","pubTime":"2023-09-05 10:11","pubTimestamp":1693879867,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,微创机器人-B跌超7%,截至发稿,跌6.96%,报17.12港元,成交额1097.52万港元。消息面上,微创机器人近日发布中期业绩。上半年实现收入4760万元,相比去年同期收入105万元实现大幅增长;归母净利润亏损5.44亿元,去年同期亏损为4.63亿元,亏幅扩大。国联证券表示,上半年公司多产品商业化进展顺利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/990854.html","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0146},{"period":"1month","weight":-0.0583},{"period":"3month","weight":-0.2551},{"period":"6month","weight":-0.3593},{"period":"1year","weight":-0.0995},{"period":"ytd","weight":-0.4308}],"websiteUrl":null,"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":-0.0364},{"period":"3month","weight":-0.0585},{"period":"6month","weight":-0.127},{"period":"1year","weight":0.0375},{"period":"ytd","weight":-0.0997}],"name":"微创机器人-B","description":"上海微创医疗机器人(集团)股份有限公司是一家从事手术器械开发的公司。 该公司的主营业务是创新手术机器人的设计、开发和商业化。该公司的产品包括图迈腔镜手术机器人、蜻蜓眼三维电子腹腔内窥镜和鸿鹄骨科手术机器人。该公司的手术机器人应用于多个微创手术领域,包括内窥镜手术、骨科手术、泛血管手术、自然腔手术和经皮穿刺手术。 该公司还提供手术机器人Medbot的教育培训服务。","exchange":"SEHK","nameEN":"MEDBOT-B","compareStock":{"symbol":"HSI","name":"恒生指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.17.2","shortVersion":"4.17.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"微创机器人-B(02252)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微创机器人-B(02252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微创机器人-B,02252,微创机器人-B股票,微创机器人-B股票老虎,微创机器人-B股票老虎国际,微创机器人-B行情,微创机器人-B股票行情,微创机器人-B股价,微创机器人-B股市,微创机器人-B股票价格,微创机器人-B股票交易,微创机器人-B股票购买,微创机器人-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微创机器人-B(02252)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微创机器人-B(02252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}